|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pilkington G, Boland A, Brown T, Oyee J,
Bagust A and Dickson R: A systematic review of the clinical
effectiveness of first-line chemotherapy for adult patients with
locally advanced or metastatic non-small cell lung cancer. Thorax.
70:359–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bienertova-Vasku J, Sana J and Slaby O:
The role of microRNAs in mitochondria in cancer. Cancer Lett.
336:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bouyssou JM, Manier S, Huynh D, Issa S,
Roccaro AM and Ghobrial IM: Regulation of microRNAs in cancer
metastasis. Biochim Biophys Acta. 1845:255–265. 2014.PubMed/NCBI
|
|
6
|
Lang Y, Xu S, Ma J, Wu J, Jin S, Cao S and
Yu Y: MicroRNA-429 induces tumorigenesis of human non-small cell
lung cancer cells and targets multiple tumor suppressor genes.
Biochem Biophys Res Commun. 450:154–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim TY, Vigil D, Der CJ and Juliano RL:
Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in
regulation of the cytoskeleton and cell motility. Cancer Metastasis
Rev. 28:77–83. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zimonjic DB and Popescu NC: Role of DLC1
tumor suppressor gene and MYC oncogene in pathogenesis of human
hepatocellular carcinoma: Potential prospects for combined targeted
therapeutics (review). Int J Oncol. 41:393–406. 2012.PubMed/NCBI
|
|
9
|
Liao YC and Lo SH: Deleted in liver
cancer-1 (DLC-1): A tumor suppressor not just for liver. Int J
Biochem Cell Biol. 40:843–847. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan BZ, Jefferson AM, Baldwin KT,
Thorgeirsson SS, Popescu NC and Reynolds SH: DLC-1 operates as a
tumor suppressor gene in human non-small cell lung carcinomas.
Oncogene. 23:1405–1411. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak and Schmittgen: Analysis of relative
gene expression data using real-time quantitative PCR and the
2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Wang L, Matyunina LV, Hill CG and
McDonald JF: Overexpression of miR-429 induces
mesenchymal-to-epithelial transition (MET) in metastatic ovarian
cancer cells. Gynecol Oncol. 121:200–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun Y, Shen S, Tang H, Xiang J, Peng Y,
Tang A, Li N, Zhou W, Wang Z, Zhang D, et al: miR-429 identified by
dynamic transcriptome analysis is a new candidate biomarker for
colorectal cancer prognosis. OMICS. 18:54–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Du L, Yang Y, Wang C, Liu H, Wang L,
Zhang X, Li W, Zheng G and Dong Z: MiR-429 is an independent
prognostic factor in colorectal cancer and exerts its
anti-apoptotic function by targeting SOX2. Cancer Lett. 329:84–90.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun Y, Shen S, Liu X, Tang H, Wang Z, Yu
Z, Li X and Wu M: MiR-429 inhibits cells growth and invasion and
regulates EMT-related marker genes by targeting Onecut2 in
colorectal carcinoma. Mol Cell Biochem. 390:19–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Li M, Zang W, Ma Y, Wang N, Li P,
Wang T and Zhao G: MiR-429 up-regulation induces apoptosis and
suppresses invasion by targeting Bcl-2 and SP-1 in esophageal
carcinoma. Cell Oncol (Dordr). 36:385–394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu D, Xia P, Diao D, Cheng Y, Zhang H,
Yuan D, Huang C and Dang C: MiRNA-429 suppresses the growth of
gastric cancer cells in vitro. J Biomed Res. 26:389–393. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun T, Wang C, Xing J and Wu D: miR-429
modulates the expression of c-myc in human gastric carcinoma cells.
Eur J Cancer. 47:2552–2559. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Liu Y, Wu S, Shi X, Li L, Zhao J
and Xu H: Tumor-suppressing effects of miR-429 on human
osteosarcoma. Cell Biochem Biophys. 70:215–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoneyama K, Ishibashi O, Kawase R, Kurose
K and Takeshita T: miR-200a, miR-200b and miR-429 are onco-mirs
that target the PTEN gene in endometrioid endometrial carcinoma.
Anticancer Res. 35:1401–1410. 2015.PubMed/NCBI
|
|
21
|
Ouyang Y, Gao P, Zhu B, Chen X, Lin F,
Wang X, Wei J and Zhang H: Downregulation of microRNA-429 inhibits
cell proliferation by targeting p27Kip1 in human prostate cancer
cells. Mol Med Rep. 11:1435–1441. 2015.PubMed/NCBI
|
|
22
|
Song B, Zheng K, Ma H, Liu A, Jing W, Shao
C, Li G and Jin G: miR-429 determines poor outcome and inhibits
pancreatic ductal adenocarcinoma growth by targeting TBK1. Cell
Physiol Biochem. 35:1846–1856. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye ZB, Ma G, Zhao YH, Xiao Y, Zhan Y, Jing
C, Gao K, Liu ZH and Yu SJ: miR-429 inhibits migration and invasion
of breast cancer cells in vitro. Int J Oncol. 46:531–538.
2015.PubMed/NCBI
|
|
24
|
Zhu W, He J, Chen D, Zhang B, Xu L, Ma H,
Liu X, Zhang Y and Le H: Expression of miR-29c, miR-93, and miR-429
as potential biomarkers for detection of early stage non-small lung
cancer. PLoS One. 9:e877802014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Healy KD, Hodgson L, Kim TY, Shutes A,
Maddileti S, Juliano RL, Hahn KM, Harden TK, Bang YJ and Der CJ:
DLC-1 suppresses non-small cell lung cancer growth and invasion by
RhoGAP-dependent and independent mechanisms. Mol Carcinog.
47:326–337. 2008. View
Article : Google Scholar : PubMed/NCBI
|
